BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026)
BridgeBio Pharma (BBIO) posted Accounts Payables of $29.1 million for Q1 2026, down 19.79% sequentially from $36.2 million in Q4 2025, and up 5.57% YoY from $27.5 million in Q1 2025.
BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026) Analysis & Trends
BridgeBio Pharma has reported Accounts Payables for 9 years, with the latest figure at $29.1 million in Q1 2026.
- Quarterly Accounts Payables rose 5.57% year-over-year to $29.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.1 million (up 5.57% YoY) and the FY2025 annual result came in at $36.2 million, up 276.67% from the prior year.
- Accounts Payables eased to $29.1 million in Q1 2026 per BBIO's latest filing, from $36.2 million in the prior quarter.
- Over five years, Accounts Payables peaked at $36.2 million in Q4 2025 and troughed at $3.9 million in Q2 2023.
- A 5-year average of $14.5 million and a median of $10.7 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables tumbled 60.62% in 2022, then soared 482.17% in 2025.
- Over 5 years, Accounts Payables stood at $11.6 million in 2022, then decreased by 7.81% to $10.7 million in 2023, then dropped by 9.73% to $9.6 million in 2024, then surged by 276.67% to $36.2 million in 2025, then retreated by 19.79% to $29.1 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $29.1 million, $36.2 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn | 27.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.20 Mn |
| Mar 31, 2026 | 29.06 Mn |
| Dec 31, 2025 | 36.23 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 26.13 Mn |
| Mar 31, 2025 | 27.53 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 13.36 Mn |
| Jun 30, 2024 | 18.13 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 10.16 Mn |
| Jun 30, 2022 | 8.79 Mn |
| Mar 31, 2022 | 10.11 Mn |
| Dec 31, 2021 | 11.88 Mn |
| Sep 30, 2021 | 12.04 Mn |